GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. (GEHC) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
GE HealthCare Technologies Inc. (GEHC) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
GEHC Unveils AI LOGIQ Ultrasound Systems to Boost Imaging & Workflow
GE HealthCare unveils next-gen LOGIQ ultrasound systems with AI and Verisound Digital tech, targeting liver disease and faster workflows to boost diagnostic precision.
Here's Why GE HealthCare Technologies (GEHC) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is GE HealthCare Technologies Inc. (GEHC) Outperforming Other Medical Stocks This Year?
Here is how GE HealthCare Technologies (GEHC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
GE HealthCare Wins FDA Clearances for Next-Gen SIGNA MRI Portfolio
GEHC wins FDA clearance for three SIGNA MRI innovations, boosting AI-driven workflows, sustainability and precision imaging capabilities.
GEHC Expands BARDA Collaboration With $35M Boost for AI Ultrasound
GE HealthCare expands its BARDA deal by $35M to speed AI-enabled ultrasound and next-gen imaging for trauma care and mass casualty readiness.
GEHC or SYK: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
GEHC Launches ReadyFix Fleet Management to Boost ECG Efficiency
GE HealthCare launches ReadyFix in the United States, a remote fleet management tool for MAC VU360 ECGs to boost device uptime and efficiency across hospitals.
GEHC Strengthens AI Fetal Ultrasound via Diagnoly Collaboration
GE HealthCare and Diagnoly unite to embed AI fetal screening in Voluson ultrasounds, expanding FDA-cleared tools to drive software-led growth and differentiation.
GE HealthCare Technologies Pops, And The Upside Isn't Over Yet
GE HealthCare Technologies delivered strong Q4 2025 results, with revenue and adjusted EPS exceeding analyst expectations and robust segmental growth. GEHC remains a 'buy' as shares are attractively valued relative to peers, despite recent outperformance and an absolute valuation near fair value. Key growth drivers include the Imaging and Pharmaceutical Diagnostics segments, innovation in cloud-first imaging, and strategic acquisitions like Intelerad.
GE HealthCare Technologies Inc. (GEHC) Q4 2025 Earnings Call Transcript
GE HealthCare Technologies Inc. (GEHC) Q4 2025 Earnings Call Transcript
GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls
GEHC tops Q4 EPS and revenue estimates as Imaging and PDx drive growth, but net margin slides on tariffs and product mix.
